Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Glossary

The Paul-Ehrlich-Institut has developed the definitions in this glossary to help users understand regulatory and biomedical terminology. Definitions may differ from those given in German and European Union legislation and medicine. Many definitions correspond to the glossary entries on the pages of the European Medicines Agency (EMA).

ADE - Antibody Dependent Enhancement

Antibody Dependent Enhancement (ADE) occur when antibodies bind to the surface of viruses, but do not neutralise them. Instead, they make it easier for the virus to enter the cell and increase the infection. For example, ADE has been observed in infections with the dengue virus.

Updated: 25.03.2020

Adjuvant

An ingredient in a medicine that increases or modifies the activity of the other ingredients. Adjuvants are often included in vaccines to enhance the body’s immune response.

Updated: 21.11.2019

Adverse Event

An untoward medical occurrence after exposure to a medicine, which is not necessarily caused by that medicine.

Updated: 21.11.2019

Adverse Reactions

Adverse reactions are noxious and unintended reactions to the medicinal product, according to section 4 paragraph 13 of the Medicinal Products Act (Arzneimittelgesetz, AMG).

It does not matter whether the adverse reaction occurred during use in keeping with the intended purpose - i.e. according to the instructions in the package leaflet or the summary of product characteristics - or whether the adverse reaction involved an overdose, a medication error, abuse, or misuse or occurred within the scope of occupational exposure.

Updated: 16.05.2022

Albumine

Albumins are proteins (proteins) which are among other things contained in the blood plasma. Human albumins are referred to as human albumins.

Updated: 21.11.2019

Allergene

An allergen is a substance which can trigger hypersensitivity reactions of the immune system thus causing allergies.

Updated: 21.11.2019

AMG - Arzneimittelgesetz

The German Medicinal Products Act (Arzneimittelgesetz, AMG) is intended to "ensure the safety relating to the marketing of medicines, in particular for the quality, efficacy and safety of the medicines in the interest of a proper supply of medicines for humans and animals" (§1 AMG).

Updated: 26.04.2023

ATMP - Advanced Therapy Medicinal Product

Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.

Updated: 26.04.2023

Authorisation Procedure

The marketing authorisation procedure checks whether a medicinal product is effective, harmless, and of the required pharmaceutical quality. The necessary registration documents will be submitted by the pharmaceutical company that intends to market the medicine.

Updated: 21.11.2019